Production (Stage)
Vigil Neuroscience, Inc.
VIGL
$7.89
$0.010.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -1.85% | -8.89% | -0.03% | -1.03% | 2.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.59% | 5.27% | -7.37% | 2.58% | 3.08% |
| Operating Income | -9.59% | -5.27% | 7.37% | -2.58% | -3.08% |
| Income Before Tax | -12.40% | -7.47% | 6.04% | -5.22% | -0.73% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.40% | -7.47% | 6.04% | -5.22% | -0.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.40% | -7.47% | 6.04% | -5.22% | -0.73% |
| EBIT | -9.59% | -5.27% | 7.37% | -2.58% | -3.08% |
| EBITDA | -9.59% | -5.29% | 7.42% | -2.58% | -2.86% |
| EPS Basic | 2.74% | -0.19% | 10.13% | -0.27% | 2.59% |
| Normalized Basic EPS | 2.72% | -0.22% | 10.15% | -0.28% | 2.62% |
| EPS Diluted | 2.74% | -0.19% | 10.13% | -0.27% | 2.59% |
| Normalized Diluted EPS | 2.72% | -0.22% | 10.15% | -0.28% | 2.62% |
| Average Basic Shares Outstanding | 15.56% | 7.27% | 4.56% | 4.93% | 3.42% |
| Average Diluted Shares Outstanding | 15.56% | 7.27% | 4.56% | 4.93% | 3.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |